Amit Shard

12PUBLICATIONS
10CO-AUTHORS
Medical infection agents (incl. prions)Biologically active moleculesMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 04, 2026
Dendronized Polymeric Biomaterial for Loading, Stabilization, and Targeted Cytosolic Delivery of microRNA in Cancer Cells.

|Feb 05, 2026
2,5-Diazabicyclo[2.2.1]heptane in medicinal chemistry: a treasure trove of therapeutic opportunities.

Pranav Kumar Ambast, Saumya Kapoor, Rudradip Das

|Oct 24, 2025
Recent progress in the development of small molecule pyruvate kinase M2 inhibitors: 2020-2025.

Rudradip Das, Shailendra Sharma, Pranav Kumar Ambast

|Oct 01, 2025
Thiazole-Based Tumor Pyruvate Kinase M2 Inhibitors: A Paradigm-Shifting Therapeutic Strategy Targeting Metabolic and Microbial Synergy in Colorectal Cancer.

Moumita Ghosh Chowdhury, Aditya A Singh, Medha Bhattacharyya

|Sep 23, 2024
Novel sulfonamides unveiled as potent anti-lung cancer agents via tumor pyruvate kinase M2 activation.

Rudradip Das, Deep Rohan Chatterjee, Saumya Kapoor

|Aug 16, 2024
Targeted suppression of oral squamous cell carcinoma by pyrimidine-tethered quinoxaline derivatives.

Asmita Choithramani, Rudradip Das, Gourav Bothra

Pageof 2

Frequent Collaborators

2 joint publications

Pinaki Sengupta

2 joint publications

Rudradip Das

2 joint publications

Deep Rohan Chatterjee

1 joint publications

Niraj Kumar Panday